Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...

Analysts at Leerink Partnrs upped their FY2024 EPS estimates for Mirum Pharmaceuticals in a research report issued to clients ...

X Genomics Inc (TXG) stock saw a decline, ending the day at $14.9 which represents a decrease of $-1.41 or -8.65% from the prior close of $16.31. The stock opened at $16.1 and touched a low of $14.19 ...

Elanco Animal Health Inc (ELAN) stock saw a decline, ending the day at $12.06 which represents a decrease of $-0.04 or -0.33% from the prior close of $12.1. The stock opened at $12.18 and touched a ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

The community living unit provides critical services for individuals with intellectual and developmental disabilities and behavioral conditions.

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Castle Biosciences (CSTL – Research Report) yesterday and set a price target ...

Throughout his career, he has held several senior leadership roles, including 11 years as a Senior Sales Trader at Leerink Partners, CEO of VenDerMoolen Institutional Services from 2007 to 2010 ...